These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31758977)

  • 1. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
    Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
    Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-seq identifies a role for the PPARβ/δ inverse agonist GSK0660 in the regulation of TNFα-induced cytokine signaling in retinal endothelial cells.
    Savage SR; McCollum GW; Yang R; Penn JS
    Mol Vis; 2015; 21():568-76. PubMed ID: 26015769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.
    Suarez S; McCollum GW; Bretz CA; Yang R; Capozzi ME; Penn JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8232-40. PubMed ID: 25406289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
    Capozzi ME; McCollum GW; Savage SR; Penn JS
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
    Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
    Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
    Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of improved PPARβ/δ inhibitors.
    Toth PM; Naruhn S; Pape VF; Dörr SM; Klebe G; Müller R; Diederich WE
    ChemMedChem; 2012 Jan; 7(1):159-70. PubMed ID: 22025402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
    Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
    Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
    Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
    Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
    Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
    Blitek A; Szymanska M
    Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.
    Shearer BG; Steger DJ; Way JM; Stanley TB; Lobe DC; Grillot DA; Iannone MA; Lazar MA; Willson TM; Billin AN
    Mol Endocrinol; 2008 Feb; 22(2):523-9. PubMed ID: 17975020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury.
    Paterniti I; Esposito E; Mazzon E; Galuppo M; Di Paola R; Bramanti P; Kapoor A; Thiemermann C; Cuzzocrea S
    J Pharmacol Exp Ther; 2010 May; 333(2):465-77. PubMed ID: 20176685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration.
    Choudhary M; Ding JD; Qi X; Boulton ME; Yao PL; Peters JM; Malek G
    Aging (Albany NY); 2016 Sep; 8(9):1952-1978. PubMed ID: 27622388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
    Toral M; Gómez-Guzmán M; Jiménez R; Romero M; Zarzuelo MJ; Utrilla MP; Hermenegildo C; Cogolludo Á; Pérez-Vizcaíno F; Gálvez J; Duarte J
    J Hypertens; 2015 Sep; 33(9):1831-44. PubMed ID: 26147382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation.
    Giblin MJ; Smith TE; Winkler G; Pendergrass HA; Kim MJ; Capozzi ME; Yang R; McCollum GW; Penn JS
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166238. PubMed ID: 34343639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.
    Yao PL; Morales JL; Gonzalez FJ; Peters JM
    Immunology; 2017 Apr; 150(4):456-467. PubMed ID: 27935639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.
    Wawrzyniak M; Pich C; Gross B; Schütz F; Fleury S; Quemener S; Sgandurra M; Bouchaert E; Moret C; Mury L; Rommens C; Mottaz H; Dombrowicz D; Michalik L
    J Allergy Clin Immunol; 2015 Jun; 135(6):1625-35.e5. PubMed ID: 25556996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.